Evaluation of the combination of gemcitabine, carboplatin, and lactate dehydrogenase A inhibitor on malignant mesothelioma.
Marika A FrańczakFederica BoreaRyszard Tomasz SmolenskiCarlotta GranchiFilippo MinutoloElisa GiovannettiGodefridus J PetersPublished in: Nucleosides, nucleotides & nucleic acids (2024)
Inhibition of LDH-A did not increase the efficacy of gemcitabine and carboplatin in MM under normoxic conditions.